TransCode Therapeutics - SEC Filing

Por um escritor misterioso
Last updated 26 abril 2025
TransCode Therapeutics - SEC Filing
TransCode Therapeutics - SEC Filing
TransCode Therapeutics - SEC Filing
TransCode Therapeutics - SEC Filing
TransCode Therapeutics - SEC Filing
TransCode Therapeutics - SEC Filing
Dominic Vacchiano on LinkedIn: 🧬 Biopharma insight for → Data
TransCode Therapeutics - SEC Filing
TransCode Therapeutics Announces Public Offering of Common Stock
TransCode Therapeutics - SEC Filing
RNAZ - TransCode Therapeutics Announces Pricing of $8 Million
TransCode Therapeutics - SEC Filing
EDGAR Filing Documents for 0001104659-21-029169
TransCode Therapeutics - SEC Filing
TransCode Therapeutics - SEC Filing
TransCode Therapeutics - SEC Filing
EDGAR Filing Documents for 0001104659-21-029169
TransCode Therapeutics - SEC Filing
ALNYLAM PHARMACEUTICALS, INC. - 10K - Annual Report - February 23
TransCode Therapeutics - SEC Filing
TransCode Therapeutics - SEC Filing
TransCode Therapeutics - SEC Filing
Oncology biotech Transcode Therapeutics files for a $30 million

© 2014-2025 atsrb.gos.pk. All rights reserved.